Total submissions: 9
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Eurofins Ntd Llc |
RCV000732861 | SCV000860857 | uncertain significance | not provided | 2018-04-10 | criteria provided, single submitter | clinical testing | |
Labcorp Genetics |
RCV001247717 | SCV001421157 | uncertain significance | Zellweger spectrum disorders | 2025-01-13 | criteria provided, single submitter | clinical testing | This variant, c.3419_3424del, results in the deletion of 2 amino acid(s) of the PEX1 protein (p.Asn1140_Gly1141del), but otherwise preserves the integrity of the reading frame. This variant is present in population databases (rs758076338, gnomAD 0.1%). This variant has not been reported in the literature in individuals affected with PEX1-related conditions. ClinVar contains an entry for this variant (Variation ID: 596889). Experimental studies and prediction algorithms are not available or were not evaluated, and the functional significance of this variant is currently unknown. In summary, the available evidence is currently insufficient to determine the role of this variant in disease. Therefore, it has been classified as a Variant of Uncertain Significance. |
Al Jalila Children’s Genomics Center, |
RCV001731913 | SCV001984006 | uncertain significance | not specified | 2020-05-14 | criteria provided, single submitter | clinical testing | |
Breakthrough Genomics, |
RCV000732861 | SCV005195966 | uncertain significance | not provided | criteria provided, single submitter | not provided | ||
Gene |
RCV000732861 | SCV005386363 | uncertain significance | not provided | 2024-01-12 | criteria provided, single submitter | clinical testing | In-frame deletion of 2 amino acids in a non-repeat region; In silico analysis supports that this variant does not alter protein structure/function; Has not been previously published as pathogenic or benign to our knowledge |
Joint Genome Diagnostic Labs from Nijmegen and Maastricht, |
RCV000732861 | SCV001951562 | uncertain significance | not provided | no assertion criteria provided | clinical testing | ||
Clinical Genetics DNA and cytogenetics Diagnostics Lab, |
RCV000732861 | SCV001967800 | uncertain significance | not provided | no assertion criteria provided | clinical testing | ||
Natera, |
RCV001247717 | SCV002076811 | uncertain significance | Zellweger spectrum disorders | 2018-05-09 | no assertion criteria provided | clinical testing | |
Prevention |
RCV003396307 | SCV004103764 | uncertain significance | PEX1-related disorder | 2024-05-22 | no assertion criteria provided | clinical testing | The PEX1 c.3419_3424del6 variant is predicted to result in an in-frame deletion (p.Asn1140_Gly1141del). To our knowledge, this variant has not been reported in the literature. This variant is reported in 0.10% of alleles in individuals of Latino descent in gnomAD (http://gnomad.broadinstitute.org/variant/7-92120599-GTTCCAT-G). At this time, the clinical significance of this variant is uncertain due to the absence of conclusive functional and genetic evidence. |